Merck & Co earnings were $13.7B for the trailing 12 months ending Jun 30, 2024, with 343.4% growth year over year. The latest MRK earnings report on Jun 30, 2024 announced Q2 2024 earnings of $5.5B, up 14.6% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, MRK reported annual earnings of $365.0M, with -97.5% growth.
MRK past earnings growth
How has MRK's earnings growth performed historically?
On MRK's earnings call on Invalid Date, Merck & Co (NYSE: MRK) reported Q2 2024 earnings per share (EPS) of $2.15, up 191.49% year over year. Total MRK earnings for the quarter were $5.46 billion. In the same quarter last year, Merck & Co's earnings per share (EPS) was -$2.35.
As of the last Merck & Co earnings report, Merck & Co is currently profitable. Merck & Co's net profit (also called net income) for the twelve months ending Jun 30, 2024 was $13.74 billion, a 341.53% increase year over year.
What was MRK's earnings growth in the past year?
As of Merck & Co's earnings date in Invalid Date, Merck & Co's earnings has grown 343.44% year over year. This is 308.55 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 34.89%. MRK earnings in the past year totalled $13.74 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.